Despite the positivity, revenue for FY2025 declined by 7.2% y-o-y to RM995.3 million, impacted by lower average selling prices (ASP) of generic healthcare gloves due to intensified competition as well as foreign exchange translation losses arising from the rapid strengthening of the Malaysian ringgit against the US dollar.
Riverstone Holdings (SGX:AP4
) has reported a net profit of RM207.8 mil for FY2025, ended Dec 31, 2025, down 27.6% y-o-y. For 4QFY2025, net profit came in 23.0% y-o-y lower at RM54.0 million.
Revenue for 4QFY2025 improved 1.3% q-o-q to RM250.7 million, driven by cleanroom demand as a result of continued expansion in data centre and AI-related industries. The company also witnessed a slight increase in sales volume for its healthcare segment.
